Chronic fluvoxamine treatment changes 5-HT(2A/2C) receptor-mediated behavior in olfactory bulbectomized mice.

[1]  Steven M. Graves,et al.  SB 206553, a putative 5-HT2C inverse agonist, attenuates methamphetamine-seeking in rats , 2012, BMC Neuroscience.

[2]  N. Alenina,et al.  Exaggerated aggression and decreased anxiety in mice deficient in brain serotonin , 2012, Translational Psychiatry.

[3]  R. Oishi,et al.  Role of endocannabinoid and glutamatergic systems in DOI-induced head-twitch response in mice , 2011, Pharmacology Biochemistry and Behavior.

[4]  J. Harvey,et al.  The role of serotonin-2 (5-HT2) and dopamine receptors in the behavioral actions of the 5-HT2A/2C agonist, DOI, and putative 5-HT2C inverse agonist, SR46349B , 2011, Psychopharmacology.

[5]  M. Diksic,et al.  Chronic buspirone treatment decreases 5-HT1B receptor densities and the serotonin transporter but increases the density of 5-HT2A receptors in the bulbectomized rat model of depression: an autoradiographic study , 2010, Brain Research.

[6]  D. Airey,et al.  The serotonin 2C receptor potently modulates the head-twitch response in mice induced by a phenethylamine hallucinogen , 2010, Psychopharmacology.

[7]  J. Nelson,et al.  Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials. , 2009, The American journal of psychiatry.

[8]  K. Hashimoto.  Sigma-1 receptors and selective serotonin reuptake inhibitors: clinical implications of their relationship. , 2009, Central nervous system agents in medicinal chemistry.

[9]  Yuko Fujita,et al.  Improvement of Phencyclidine-Induced Cognitive Deficits in Mice by Subsequent Subchronic Administration of Fluvoxamine, but not Sertraline , 2009 .

[10]  K. Berg,et al.  Current status of inverse agonism at serotonin2A (5-HT2A) and 5-HT2C receptors. , 2009, Pharmacology & therapeutics.

[11]  Daniel Hoyer,et al.  Molecular biology of 5-HT receptors , 2008, Behavioural Brain Research.

[12]  Yuko Fujita,et al.  Phencyclidine-Induced Cognitive Deficits in Mice are Improved by Subsequent Subchronic Administration of Fluvoxamine: Role of Sigma-1 Receptors , 2007, Neuropsychopharmacology.

[13]  J. Kamei,et al.  Effects of milnacipran and fluvoxamine on hyperemotional behaviors and the loss of tryptophan hydroxylase-positive cells in olfactory bulbectomized rats , 2007, Psychopharmacology.

[14]  T. Imanishi,et al.  Desensitization of 5-HT2A receptor function by chronic administration of selective serotonin reuptake inhibitors , 2006, Brain Research.

[15]  B. Leonard,et al.  The olfactory bulbectomised rat as a model of depression , 2005, Neuroscience & Biobehavioral Reviews.

[16]  G. Debonnel,et al.  Chronic administration of citalopram in olfactory bulbectomy rats restores brain 5-HT synthesis rates: an autoradiographic study , 2005, Psychopharmacology.

[17]  T. Imanishi,et al.  Chronic treatment with fluvoxamine desensitizes 5-HT2C receptor-mediated hypolocomotion in rats , 2004, Pharmacology Biochemistry and Behavior.

[18]  K. Tan-No,et al.  Effects of NMDA receptor-related agonists on learning and memory impairment in olfactory bulbectomized mice. , 2004, Methods and findings in experimental and clinical pharmacology.

[19]  K. Tan-No,et al.  Enhancement of 5-hydroxytryptamine-induced head-twitch response after olfactory bulbectomy , 2003, Neuroscience.

[20]  G. Debonnel,et al.  Regional brain serotonin synthesis is increased in the olfactory bulbectomy rat model of depression: an autoradiographic study , 2003, Journal of neurochemistry.

[21]  C. Wichems,et al.  Brain region‐specific alterations of 5‐HT2A and 5‐HT2C receptors in serotonin transporter knockout mice , 2003, Journal of neurochemistry.

[22]  C. McDougle,et al.  Synergistic Action of 5-HT2A Antagonists and Selective Serotonin Reuptake Inhibitors in Neuropsychiatric Disorders , 2003, Neuropsychopharmacology.

[23]  Patricia M. Whitaker-Azmitia,et al.  Serotonin and brain development: role in human developmental diseases , 2001, Brain Research Bulletin.

[24]  G. Kennett,et al.  Comparative effects of continuous infusion of mCPP, Ro 60‐0175 and d‐fenfluramine on food intake, water intake, body weight and locomotor activity in rats , 2000, British journal of pharmacology.

[25]  J John Mann,et al.  Role of the Serotonergic System in the Pathogenesis of Major Depression and Suicidal Behavior , 1999, Neuropsychopharmacology.

[26]  Trevor Sharp,et al.  A review of central 5-HT receptors and their function , 1999, Neuropharmacology.

[27]  A. Becker,et al.  Serotonergic hyperinnervation of the frontal cortex in an animal model of depression, the bulbectomized rat , 1998, Journal of neuroscience research.

[28]  G. Kennett,et al.  Effect of chronic m‐CPP on locomotion, hypophagia, plasma corticosterone and 5‐HT2C receptor levels in the rat , 1998, British journal of pharmacology.

[29]  S. Hamada,et al.  Localization of 5-HT2A receptor in rat cerebral cortex and olfactory system revealed by immunohistochemistry using two antibodies raised in rabbit and chicken. , 1998, Brain research. Molecular brain research.

[30]  B. Sabel,et al.  Influence of olfactory bulbectomy and subsequent imipramine treatment on 5‐hydroxytryptaminergic presynapses in the rat frontal cortex: behavioural correlates , 1997, British journal of pharmacology.

[31]  H. Meltzer,et al.  Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats. , 1997, The Journal of pharmacology and experimental therapeutics.

[32]  P. Cowen,et al.  5-HT2C receptor activation decreases appetite and body weight in obese subjects , 1997, Psychopharmacology.

[33]  N. Otmakhova,et al.  Bulbectomy-induced loss of raphe neurons is counteracted bt antidepressant treatment , 1997, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[34]  F. Blaney,et al.  5-HT2 receptor subtypes: a family re-united? , 1995, Trends in pharmacological sciences.

[35]  H. Kinemuchi,et al.  Alpha-methylated tryptamine derivatives induce a 5-HT receptor-mediated head-twitch response in mice , 1995, Neuropharmacology.

[36]  B. Leonard,et al.  Autoradiographic distribution of cholinergic muscarinic receptors and serotonin2 receptors in olfactory bulbectomized (OB) rats after chronic treatment with mianserin and desipramine , 1994 .

[37]  B. Roth.  Multiple serotonin receptors: clinical and experimental aspects. , 1994, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

[38]  M. Palkovits,et al.  5-HT uptake sites and 5-HT2 receptors in brain of antidepressant-free suicide victims/depressives: increase in 5-HT2 sites in cortex and amygdala , 1993, Brain Research.

[39]  Martin H. Teicher,et al.  Olfactory bulbectomy as a model for agitated hyposerotonergic depression , 1992, Brain Research.

[40]  R. Glennon,et al.  Do functional relationships exist between 5-HT1A and 5-HT2 receptors? , 1990, Pharmacology Biochemistry and Behavior.

[41]  I. Ferrier,et al.  5HT2 receptor changes in major depression , 1990, Biological Psychiatry.

[42]  G. Kennett,et al.  Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists. , 1989, European journal of pharmacology.

[43]  B. Leonard,et al.  The chronic effects of desipramine and sertraline on platelet and synaptosomal 5HT uptake in olfactory bulbectomised rats , 1988, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[44]  G. Kennett,et al.  Evidence that mCPP may have behavioural effects mediated by central 5‐HT1C receptors , 1988, British journal of pharmacology.

[45]  J. Richardson,et al.  Brain output dysregulation induced by olfactory bulbectomy: an approximation in the rat of major depressive disorder in humans? , 1988, The International journal of neuroscience.

[46]  M. Shipley,et al.  Serotonergic afferents to the rat olfactory bulb: II. Changes in fiber distribution during development , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[47]  T. Kuno,et al.  Decreased serotonin S2 and increased dopamine D2 receptors in chronic schizophrenics , 1986, Biological Psychiatry.

[48]  S. Leibowitz,et al.  Hypothalamic serotonin in the control of meal patterns and macronutrient selection , 1986, Brain Research Bulletin.

[49]  B. McEwen,et al.  Increased serotonin2 and beta-adrenergic receptor binding in the frontal cortices of suicide victims. , 1986, Archives of general psychiatry.

[50]  D. Heal,et al.  Intracerebroventricular administration of 5,7-dihydroxytryptamine to mice increases both head-twitch response and the number of cortical 5-HT2 receptors , 1985, Neuropharmacology.

[51]  B. Leonard,et al.  Changes in neurotransmitter metabolism following olfactory bulbectomy in the rat , 1984, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[52]  F. Macrides,et al.  Olfactory bulbectomy impairs the rat's radial-maze behavior , 1983, Physiology & Behavior.

[53]  C. Pycock,et al.  ‘Wet-Dog’ shake behaviour in the rat: A possible quantitative model of central 5-hydroxytryptamine activity , 1977, Neuropharmacology.

[54]  V. Denenberg,et al.  Influence of olfactory bulbectomy and the serotonergic system upon intermale aggression and maternal behavior in the mouse , 1975, Pharmacology Biochemistry and Behavior.

[55]  D. Cain.  The role of the olfactory bulb in limbic mechanisms. , 1974, Psychological bulletin.

[56]  M. Sieck,et al.  The role of the olfactory system in avoidance learning and activity. , 1972, Physiology & behavior.

[57]  S. Fox,et al.  Neurobiological basis of serotonin-dopamine antagonists in the treatment of Gilles de la Tourette syndrome. , 2008, Progress in brain research.

[58]  J. Prickaerts,et al.  The dorsal raphe nucleus and serotonin: implications for neuroplasticity linked to major depression and Alzheimer's disease. , 2008, Progress in brain research.

[59]  G. Kennett,et al.  Evidence that hypophagia induced bymCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU 24969 only requires 5-HT1B receptors , 2006, Psychopharmacology.

[60]  E. Rüther,et al.  Long-term modulation of presynaptic 5-HT-output: Experimentally induced changes in cortical 5-HT-transporter density, tryptophan hydroxylase content and 5-HT innervation density , 2005, Journal of Neural Transmission.

[61]  F. Verhey,et al.  Serotonergic mechanisms in Parkinson’s disease: opposing results from preclinical and clinical data , 2005, Journal of Neural Transmission.

[62]  J. Kelly,et al.  The olfactory bulbectomized rat as a model of depression: an update. , 1997, Pharmacology & therapeutics.

[63]  B. Leonard,et al.  The effect of olfactory bulbectomy in the rat, alone or in combination with antidepressants and endogenous factors, on immune function , 1995 .

[64]  E. sanders-Bush.  Neurochemical evidence that hallucinogenic drugs are 5-HT1c receptor agonists: what next? , 1994, NIDA research monograph.

[65]  B. Leonard,et al.  Effects of psychotropic drugs on the behavior and neurochemistry of olfactory bulbectomized rats. , 1990, Pharmacology & therapeutics.

[66]  I. Lucki,et al.  Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat. , 1984, The Journal of pharmacology and experimental therapeutics.

[67]  T. Sakurada,et al.  Effects of p-chlorophenylalanine (p-CPA) on sleep in olfactory bulb lesioned rats. , 1977, Japanese journal of pharmacology.

[68]  K. Larsson.  Impaired mating performances in male rats after anosmia induced peripherally or centrally. , 1971, Brain, behavior and evolution.